Intellus Advisors LLC Invests $824,000 in UnitedHealth Group Incorporated (NYSE:UNH)

Intellus Advisors LLC bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, HoldingsChannel.com reports. The fund bought 1,628 shares of the healthcare conglomerate’s stock, valued at approximately $824,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. NewSquare Capital LLC purchased a new position in UnitedHealth Group during the 4th quarter worth $25,000. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group in the 4th quarter worth $30,000. Promus Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at about $32,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group during the third quarter valued at about $37,000. Finally, Pillar Financial Advisors LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $40,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on UNH shares. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Stephens lifted their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Wells Fargo & Company cut their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Finally, Truist Financial lowered their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Twenty investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Price Performance

UNH stock opened at $517.72 on Friday. The stock has a market cap of $473.57 billion, a price-to-earnings ratio of 33.40, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The business has a fifty day moving average of $510.19 and a two-hundred day moving average of $547.47.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the firm posted $5.83 earnings per share. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.62%. UnitedHealth Group’s payout ratio is presently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.